Lantern Pharma Stock Market Value
| LTRN Stock | USD 4.81 0.26 5.71% |
| Symbol | Lantern |
Lantern Pharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lantern Pharma. If investors know Lantern will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lantern Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lantern Pharma is measured differently than its book value, which is the value of Lantern that is recorded on the company's balance sheet. Investors also form their own opinion of Lantern Pharma's value that differs from its market value or its book value, called intrinsic value, which is Lantern Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lantern Pharma's market value can be influenced by many factors that don't directly affect Lantern Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lantern Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lantern Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lantern Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lantern Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lantern Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lantern Pharma.
| 01/01/2025 |
| 01/31/2025 |
If you would invest 0.00 in Lantern Pharma on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Lantern Pharma or generate 0.0% return on investment in Lantern Pharma over 30 days. Lantern Pharma is related to or competes with Generation Bio, Lyra Therapeutics, Immunome, and Cue Biopharma. Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and g... More
Lantern Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lantern Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lantern Pharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.37 | |||
| Information Ratio | 0.0893 | |||
| Maximum Drawdown | 44.5 | |||
| Value At Risk | (8.59) | |||
| Potential Upside | 13.33 |
Lantern Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lantern Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lantern Pharma's standard deviation. In reality, there are many statistical measures that can use Lantern Pharma historical prices to predict the future Lantern Pharma's volatility.| Risk Adjusted Performance | 0.0948 | |||
| Jensen Alpha | 0.7258 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.1219 | |||
| Treynor Ratio | 3.52 |
Lantern Pharma Backtested Returns
Lantern Pharma appears to be relatively risky, given 3 months investment horizon. Lantern Pharma has Sharpe Ratio of 0.12, which conveys that the firm had a 0.12 % return per unit of risk over the last 3 months. By analyzing Lantern Pharma's technical indicators, you can evaluate if the expected return of 0.91% is justified by implied risk. Please exercise Lantern Pharma's Risk Adjusted Performance of 0.0948, downside deviation of 5.37, and Mean Deviation of 5.3 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Lantern Pharma holds a performance score of 9. The company secures a Beta (Market Risk) of 0.21, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Lantern Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Lantern Pharma is expected to be smaller as well. Please check Lantern Pharma's maximum drawdown, as well as the relationship between the expected short fall and rate of daily change , to make a quick decision on whether Lantern Pharma's current price movements will revert.
Auto-correlation | 0.13 |
Insignificant predictability
Lantern Pharma has insignificant predictability. Overlapping area represents the amount of predictability between Lantern Pharma time series from 1st of January 2025 to 16th of January 2025 and 16th of January 2025 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lantern Pharma price movement. The serial correlation of 0.13 indicates that less than 13.0% of current Lantern Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.13 | |
| Spearman Rank Test | 0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.26 |
Lantern Pharma lagged returns against current returns
Autocorrelation, which is Lantern Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lantern Pharma's stock expected returns. We can calculate the autocorrelation of Lantern Pharma returns to help us make a trade decision. For example, suppose you find that Lantern Pharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lantern Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lantern Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lantern Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lantern Pharma stock over time.
Current vs Lagged Prices |
| Timeline |
Lantern Pharma Lagged Returns
When evaluating Lantern Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lantern Pharma stock have on its future price. Lantern Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lantern Pharma autocorrelation shows the relationship between Lantern Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Lantern Pharma.
Regressed Prices |
| Timeline |
Pair Trading with Lantern Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lantern Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Lantern Stock
| 0.49 | INZY | Inozyme Pharma | PairCorr |
| 0.47 | LPTX | Leap Therapeutics | PairCorr |
| 0.4 | MREO | Mereo BioPharma Group | PairCorr |
| 0.37 | KRYS | Krystal Biotech | PairCorr |
| 0.33 | PDSB | PDS Biotechnology Corp | PairCorr |
The ability to find closely correlated positions to Lantern Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lantern Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lantern Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lantern Pharma to buy it.
The correlation of Lantern Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lantern Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lantern Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lantern Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Lantern Pharma Correlation, Lantern Pharma Volatility and Lantern Pharma Alpha and Beta module to complement your research on Lantern Pharma. To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Lantern Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.